文献速递皮肤肿瘤

器官获取移植网络皮肤癌报告效度验证:队列研究

Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study.
PubMed 文献 · J Am Acad Dermatol · 2017-10-12

本研究将4934例实体器官移植受者与OPTN恶性数据关联,比较OPTN对移植后鳞状细胞癌和恶性黑色素瘤的报告与病历复核数据的效度。结果显示OPTN报告敏感性低但特异性极高。

要点

  • OPTN对SCC和MM的报告敏感性低,特异性高。
  • 皮肤科和移植医生应加强沟通和报告以提高数据效度。

核心结论

  • OPTN对SCC和MM的报告敏感性差但特异性好。
  • 建议皮肤科和移植医生通过改进沟通和报告提升OPTN皮肤癌数据效度。

研究设计与样本

  • 队列研究,比较OPTN报告与TSCN数据库病历复核数据,共4934例器官移植受者链接到OPTN恶性数据。

主要发现

  • SCC(人群患病率11%)OPTN报告的敏感性41%,特异性99%,PPV 88%,NPV 93%,CC 93%。
  • MM(人群患病率1%)OPTN报告的敏感性22%,特异性100%,PPV 73%,NPV 99%,CC 99%。

关键数值与推荐

  • SCC:敏感性41%,特异性99%,PPV 88%,NPV 93%,CC 93%(人群患病率11%)。
  • MM:敏感性22%,特异性100%,PPV 73%,NPV 99%,CC 99%(人群患病率1%)。

临床怎么用

  • 临床应认识到OPTN皮肤癌数据敏感性低,直接用于研究可能低估事件。
  • 皮肤科和移植医生应主动沟通并完善报告以提高数据质量。

局限性

  • 仅部分TSCN队列患者有匹配的UNOS癌症登记数据可供比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Organ Procurement Transplant Network (OPTN) registry collects data on posttransplant malignancies in solid organ transplant recipients. Complete and accurate registry data on skin cancer is critical for research on epidemiology and interventions. OBJECTIVE: The study goal was to determine the validity of Organ Procurement Transplant Network skin cancer data. METHODS: This cohort study compared reporting of posttransplant squamous cell carcinoma (SCC) and malignant melanoma (MM) in OPTN to medical-record review-derived data from the Transplant Skin Cancer Network (TSCN) database. In total, 4934 organ transplant recipients from the TSCN database were linked to patient-level OPTN malignancy data. We calculated sensitivity, specificity, correct classification (CC), positive predictive value (PPV), and negative predictive value (NPV) for SCC and MM reporting in the OPTN database. RESULTS: OPTN reporting for SCC (population prevalence 11%) had sensitivity 41%, specificity 99%, PPV 88%, NPV 93%, and CC 93%. OPTN reporting for MM (population prevalence 1%) had sensitivity 22%, specificity 100%, PPV 73%, NPV 99%, and CC 99%. LIMITATIONS: Only a subset of patients in the TSCN cohort had matched United Network for Organ Sharing cancer registry data for comparison. CONCLUSION: OPTN reporting had poor sensitivity but excellent specificity for SCC and MM. Dermatologists and transplant physicians are encouraged to improve the validity of OPTN skin cancer data through improved communication and reporting.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Garrett GL, Yuan JT, Shin TM, et al. Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study. J Am Acad Dermatol. 2017. PMID: 29031659. doi:10.1016/j.jaad.2017.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。